重庆地区40家医院2008～2010年抗糖尿病药利用分析  

Analysis of antidiabetic agents used in 40 hospitals of Chongqing during 2008-2010

作　　者：杨佳丹[1] 陈庆宪[1] 欧阳净[2] 

机构地区：[1]重庆医科大学附属第一医院药剂科,400016 [2]第三军医大学西南医院药剂科,重庆400038

出　　处：《重庆医学》2012年第26期2751-2754,共4页Chongqing medicine

摘　　要：目的评价重庆地区医院抗糖尿病药的应用情况和发展趋势。方法采用回顾性方法,对重庆地区40家医院2008～2010年抗糖尿病药的销售金额、用药频度(DDDs)、日均费用(DDC)等数据进行统计、分析。结果各年度抗糖尿病药品销售金额呈逐年上升趋势,销售金额排序前3位的分别是阿卡波糖、罗格列酮、瑞格列奈,DDDs排序列前3位的分别是消渴丸、二甲双胍、瑞格列奈。结论该市口服降糖药种类全面,新型降糖药得到应用。Objective To evaluate the clinical application and developing trends of antidiabetic agents in the hospitals of Chongqing area.Methods The retrospective method was used to conduct the statistical analysis on the application status of antidiabetic agents in the hospitals of Chongqing area from 2008 to 2010,including the consumption sum,medication frequency（DDDs）,daily costs（DDC）,etc.Results The consumption sum of antidiabetic agents during the period 2008-2010 was increasing year by year.During this period,the top 3 antidiabetic agents in respect of the cost list were acarbose,rosiglitazone and repaglinide.The top 3 antidiabetic agents in respect of the medication frequency list were Xiaoke Pills,metformin and repaglinide.Conclusion Types of oral hypoglycemic agents are complete and the new type antidiabetic agents are used.

关 键 词：回顾性研究 糖尿病 费用 药物 用药频度 

分 类 号：R95[医药卫生—药学]